Immunotherapy Approaches in HPV-Associated Head and Neck Cancer

Immunotherapy Approaches in HPV-Associated Head and Neck Cancer

Immunotherapy approaches for head and neck squamous cell carcinoma (HNSCC) are rapidly advancing. Human papillomavirus (HPV) has been identified as a causative agent in a subset of oropharyngeal cancers (OPC). HPV-positive OPC comprises a distinct clinical and pathologic disease entity and has a uni...

Full description

Bibliographic Details
Main Authors: Ricklie Julian, Malvi Savani, Julie E. Bauman
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Cancers
Subjects:
head and neck squamous cell carcinoma
novel therapies
human papillomavirus
immunotherapy
Online Access:https://www.mdpi.com/2072-6694/13/23/5889

Internet

https://www.mdpi.com/2072-6694/13/23/5889

Similar Items